Schreck Michael, Executive Vice President at IDXX (Idexx Laboratories), has demonstrated a consistent pattern of selling activity over the past three years, with no recorded purchases in the same period. According to SEC Form 4 filings, all 26 of his reported transactions involved sales of IDXX stock, totaling $812,933.85 in aggregate value. The most notable disposals occurred on February 14, 2026, when he sold shares worth $551,310.60, followed by a $196,037.73 transaction on February 14, 2025, and a $65,585.52 sale on February 14, 2024. These transactions suggest a recurring annual disposition of holdings, with the largest sale occurring most recently.
The filings indicate that Schreck’s sales were executed under transaction codes "F" (indicating an open-market sale) and "M" (exercise of derivative securities), though the latter had no reported monetary value. The absence of any buy transactions—coupled with the increasing size of his annual sales—points to a sustained reduction in his IDXX position. While the filings do not disclose the reasons behind these disposals, the pattern aligns with scheduled stock sales, possibly tied to vesting events or prearranged trading plans. His activity remains exclusively tied to IDXX, with no trades reported in other securities.
AI-assisted summary